Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes

Archives of Ophthalmology

Volumn 127, Issue 8, 2009, Pages 989-998

  Shields, Carol L ^a   Furuta, Minoru ^a   Thangappan, Archana ^a   Nagori, Saya ^a   Mashayekhi, Arman ^a   Lally, David R ^a   Kelly, Cecilia C ^a   Rudich, Danielle S ^a   Nagori, Anand V ^a   Wakade, Oojwala A ^a   Mehta, Sonul ^a   Forte, Lauren ^a   Long, Andrew ^a   Dellacava, Elaina F ^a   Kaplan, Bonnie ^a   Shields, Jerry A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CHILD; CHOROID MELANOMA; CILIARY BODY TUMOR; CRYOTHERAPY; ENUCLEATION; EVISCERATION; FEMALE; HUMAN; HYPERTHERMIC THERAPY; INTRAOCULAR HEMORRHAGE; IRIS TUMOR; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METASTASIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SUBRETINAL FLUID; THICKNESS; TUMOR GROWTH; TUMOR VOLUME; UVEA MELANOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CHILD; CHILD, PRESCHOOL; CRYOTHERAPY; EYE ENUCLEATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTHERMIA, INDUCED; LASER COAGULATION; LIVER NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; UVEAL NEOPLASMS; YOUNG ADULT;

EID: 68549115574     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2009.208     Document Type: Article

References (26)

1. Paul EF, Parnell BC, Fraker M. Prognosis of malignant melanomas of the choroid and ciliary body. Int Ophthalmol Clin. 1962;2:387-402.
2. Diener-West M, Hawkins BS, Markowitz JA, Schachat AP. A review of mortality from choroidal melanoma, II: a meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol. 1992;110(2):245-250.
3. Diener-West M, Earle JD, Fine SL, et al; Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings: COMS report No. 18. Arch Ophthalmol. 2001;119(7):969-982.
4. Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, V: 12-year mortality rates and prognostic factors: COMS report No. 28. Arch Ophthalmol. 2006;124(12):1684-1693.
5. Collaborative Ocular Melanoma Study Group. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma, II: initial mortality findings: COMS report No. 10. Am J Ophthalmol. 1998;125(6):779-796.
6. Hawkins BS; Collaborative Ocular Melanoma Study Group. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma, IV: 10-year mortality findings and prognostic factors: COMS report No. 24. Am J Ophthalmol. 2004;138(6):936-951.
7. Shields JA, Shields CL. Prognostic factors for uveal melanoma. In: Gospodarowicz M, O'Sullivan B, Sobin LH, eds. Prognostic Factors in Cancer. 3rd ed. Hoboken, NJ: Wiley-Liss Inc; 2006:269-272.
8. Shields JA, Shields CL. Intraocular Tumors: An Atlas and Textbook. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008:85-175.
9. Kujala E, Mäkitie T, Kivelä T. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2003;44(11):4651-4659.
10. Damato B, Eleuteri A, Fisher AC, Coupland SE, Taktak AF. Artificial neural networks estimating survival probability after treatment of choroidal melanoma. Ophthalmology. 2008;115(9):1598-1607.
11. Shields CL. The hunt for the secrets of uveal melanoma: perspective [editorial]. Clin Exp Ophthalmol. 2008;36:277-280.
12. Collaborative Ocular Melanoma Study Group. Comparison of clinical, echographic, and histopathological measurements from eyes with medium-sized choroidal melanoma in the Collaborative Ocular Melanoma Study: COMS report No. 21. Arch Ophthalmol. 2003;121(8):1163-1171.
13. McLean IW, Foster WD, Zimmerman LE, Martin DG. Inferred natural history of uveal melanoma. Invest Ophthalmol Vis Sci. 1980;19(7):760-770.
14. Shields CL, Shields JA, De Potter P, Cater J, Tardio D, Barrett J. Diffuse choroidal melanoma: clinical features predictive of metastasis. Arch Ophthalmol. 1996;114(8):956-963.
15. Demirci H, Shields CL, Shields JA, Eagle RC Jr, Honavar SG. Diffuse iris melanoma: a report of 25 cases. Ophthalmology. 2002;109(8):1553-1560.
16. Hoersch B, Leiter U, Garbe C. Is head and neck melanoma a distinct entity? a clinical registry-based comparative study in 5702 patients with melanoma. Br J Dermatol. 2006;155(4):771-777.
17. Pennie ML, Soon SL, Risser JB, Veledar E, Culler SD, Chen SC. Melanoma outcomes for Medicare patients: association of stage and survival with detection by a dermatologist vs a nondermatologist. Arch Dermatol. 2007;143(4):488-494.
18. Downing A, Yu XQ, Neweton-Bishop J, Forman D. Trends in prognostic factors and survival from cutaneous melanoma in Yorkshire, UK and New South Wales, Australia between 1993-2003. Int J Cancer. 2008;123(4):861-868.
19. Sartore L, Papanikolaou GE, Biancari F, Mazzoleni F. Prognostic factors of cutaneous melanoma in relation to metastasis at the sentinel lymph node: a case-controlled study. Int J Surg. 2008;6(3):205-209.
20. Guitera P, Li LX, Crotty K, et al. Melanoma histological Breslow thickness predicted by 75-MHz ultrasonography. Br J Dermatol. 2008;159(2):364-369.
21. Coupland SE, Campbell I, Damato B. Routes of extraocular extension of uveal melanoma risk factors and influence on survival probability. Ophthalmology. 2008;115(10):1778-1785.
22. Damato B, Duke C, Coupland SE, et al. Cytogenetics of uveal melanoma: a 7-year clinical experience. Ophthalmology. 2007;114(10):1925-1931.
23. Eskelin S, Pyrhönen S, Summanen P, Hahka-Kemppinen M, Kivelä T. Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment. Ophthalmology. 2000;107(8):1443-1449.
24. Eskelin S, Kivela T. Uveal melanoma: implications of tumor doubling time [author's reply]. Ophthalmology. 2001;108:830-831.
25. Eskelin S, Pyrhönen S, Summanen P, Prause JU, Kivelä T. Screening for metastatic malignant melanoma of the uvea revisited. Cancer. 1999;85(5):1151-1159.
26. Diener-West M, Reynolds SM, Agugliaro DJ, et al; Collaborative Ocular Melanoma Study Group Report 23. Screening for metastasis from choroidal melanoma: the Collaborative Ocular Melanoma Study Group report 23. J Clin Oncol. 2004;22(12):2438-2444.